Meropenem
- Half-Life (t½)
- IV: 1h
- Formula
- C17H25N3O5S
- Molecular Weight
- 437.52 g/mol
- Aliases
- Merrem
Pharmacological Mechanism
Carbapenem β-lactam — very broad spectrum (gram-positive, gram-negative including Pseudomonas + ESBL producers, anaerobes). Reserved for severe infections + ESBL-producing organisms. Lower seizure risk than imipenem.
Half-Life & Elimination Curve (IV: 1h)
Elimination (IV)
- 0×t½0h100% (49 mg/L)
- 1×t½1h50% (24.5 mg/L)
- 2×t½2h25% (12.3 mg/L)
- 3×t½3h12.5% (6.13 mg/L)
- 4×t½4h6.3% (3.06 mg/L)
- 5×t½5h3.1% (1.53 mg/L)
Dosing Guidelines
- Intravenous (IV): Typical 1000 mg (Range: 500–2000 mg)
Pharmacokinetic Parameters
- Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 20.4 L [PMID 2055812]
Pathways It Modulates
Target Organ Systems
Chemical Structure & Identifiers
- InChIKey: DMJNNHOOLUXYBV-PQTSNVLCSA-N
- SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
References